Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP81054.RAKSjdK_sGvMkMfIV0Qc_E9foP-6EedoRNRCIU7VftsUg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP81054.RAKSjdK_sGvMkMfIV0Qc_E9foP-6EedoRNRCIU7VftsUg130_assertion type Assertion NP81054.RAKSjdK_sGvMkMfIV0Qc_E9foP-6EedoRNRCIU7VftsUg130_head.
- NP81054.RAKSjdK_sGvMkMfIV0Qc_E9foP-6EedoRNRCIU7VftsUg130_assertion description "[Clinical comparison of SOD1, TARDBP, FUS and other familial ALS patients (with no mutation in the screened genes) revealed differences in site of onset (predominantly lower limbs for SOD1 and upper limbs for TARDBP mutations), age of onset (younger with FUS mutations), and in lifespan (shorter for FUS carriers).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP81054.RAKSjdK_sGvMkMfIV0Qc_E9foP-6EedoRNRCIU7VftsUg130_provenance.
- NP81054.RAKSjdK_sGvMkMfIV0Qc_E9foP-6EedoRNRCIU7VftsUg130_assertion evidence source_evidence_literature NP81054.RAKSjdK_sGvMkMfIV0Qc_E9foP-6EedoRNRCIU7VftsUg130_provenance.
- NP81054.RAKSjdK_sGvMkMfIV0Qc_E9foP-6EedoRNRCIU7VftsUg130_assertion SIO_000772 20577002 NP81054.RAKSjdK_sGvMkMfIV0Qc_E9foP-6EedoRNRCIU7VftsUg130_provenance.
- NP81054.RAKSjdK_sGvMkMfIV0Qc_E9foP-6EedoRNRCIU7VftsUg130_assertion wasDerivedFrom gad-20130706 NP81054.RAKSjdK_sGvMkMfIV0Qc_E9foP-6EedoRNRCIU7VftsUg130_provenance.
- NP81054.RAKSjdK_sGvMkMfIV0Qc_E9foP-6EedoRNRCIU7VftsUg130_assertion wasGeneratedBy ECO_0000203 NP81054.RAKSjdK_sGvMkMfIV0Qc_E9foP-6EedoRNRCIU7VftsUg130_provenance.